ZeroStack Corp. Common Stock (ZSTK) Stock Price
ZSTKStock
$4.00−78.95%52W
Market Cap$87.19M
P/E—
PEG Ratio—
Div yield—
Beta2.11
ZSTK Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-42.11%
Price vs S&P 500 (4W)-6.08%
VGM Score38.64
ZSTK Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.11 | -$2.47 | -2145.45%(-$2.36) | |
| Q1 2026 | — | -$3.68 | — | |
| Q4 2025 | -$0.39 | -$34.29 | -8692.31%(-$33.90) | |
| Q2 2025 | -$2.34 | -$4.54 | -93.83%(-$2.20) |
ZSTK Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.14
4.14
4.14
4.14
Industry Peers — Drug Wholesale(11)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | ROE (TTM) | Operating Margin (TTM) | Revenue Growth TTM (YoY) | Price |
|---|---|---|---|---|---|---|---|---|
ZSTKZeroStack Corp. Common Stock | — | D | C | — | -382.3% | -595.2% | — | $4.00 |
| MCKMcKesson Corporation | D | B | B | 24.6x | 39.4% | 1.6% | 8.8% | $1004.84 |
| CORCencora, Inc. | D | B | B | 41.9x | 106.4% | 0.9% | 5.1% | $340.92 |
| CAHCardinal Health, Inc. | D | B | A | 34.3x | 37.2% | 1.0% | 14.2% | $254.06 |
| HLFHerbalife Ltd. | B | D | A | 6.7x | 170.7% | -14.1% | 5.5% | $14.60 |
| NUSNuSkin Enterprises, Inc. | B | F | C | 1.6x | -29.4% | -0.8% | -15.4% | $5.14 |
| WGRXWellgistics Health, Inc. Common Stock | D | F | D | — | -1645.9% | -506.9% | -51.6% | $4.28 |
| ESYNEnerSyn Global Inc. Common Stock | — | — | C | — | — | — | — | $1.94 |
| COSMCosmos Holdings Inc. Common Stock | D | B | C | — | -118.9% | -24.8% | 33.8% | $0.33 |
| HWHHWH International Inc. Common Stock | F | D | B | — | -103.9% | -716.1% | -68.5% | $1.98 |
| MEDSDataMeds AI, Inc. Common Stock | D | D | D | — | -1645.9% | -1034.0% | -78.2% | $2.63 |
About ZeroStack Corp. Common Stock
ZeroStack Corp is an asset management company providing exposure to decentralized AI through digital assets and staking strategies. The company generates yield and fee-based income from staking validators, compute infrastructure technology, and complementary AI-focused investments. ZeroStack also operates a global pharmaceutical distribution business through its wholly owned subsidiary.